Brief: Huakang Biomedical Holdings Clarifies Media Reports Concerning Acquisition Of Co
31/01/2022 06:59
Jan 31 (Reuters) - Huakang Biomedical Holdings Co Ltd
8622.HK :
* CLARIFIES MEDIA REPORTS CONCERNING ACQUISITION OF CO
* CONFIRMED REPORTS ON ALLEGED ACQUISITION ARE "UNTRUE"
Further company coverage: 8622.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Joyzyme
See all newsChairman
Brief: Huakang Biomedical Trading In Co's Shares Halted
Brief: Huakang Biomedical Says Zhang Shuguang Resigns As Executive Director And Chairman
Brief: Huakang Biomedical Announces Zhang Yujing Appointed As Executive Director
Brief: Huakang Biomedical To Acquire 51% Interest In Hunan Keyue Biotechnology